Changes in the characteristics and outcomes of COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study-Reference-Cited by-同舟云学术

Changes in the characteristics and outcomes of COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study

Published:2022-12-20 Issue:1 Volume:12 Page:
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Miyashita Koichi¹,Hozumi Hironao¹^ORCID,Furuhashi Kazuki¹,Nakatani Eiji²,Inoue Yusuke¹,Yasui Hideki¹,Karayama Masato¹,Suzuki Yuzo¹^ORCID,Fujisawa Tomoyuki¹,Enomoto Noriyuki¹,Inui Naoki³,Ojima Toshiyuki⁴,Suda Takafumi¹

Affiliation:

1. Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan

2. Graduate School of Public Health, Shizuoka Graduate University of Public Health, Shizuoka, Japan

3. Department of Clinical Pharmacology and Therapeutics, Hamamatsu University School of Medicine, Hamamatsu, Japan

4. Department of Community Health and Preventive Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan

Funder

Study Group on Diffuse Lung Disease

Ministry of Health, Labour and Welfare

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/22221751.2022.2155250

Reference36 articles.

1. World Health Organization: WHO Coronavirus (COVID-19) Dashboard. [cited 2022 May 2]. Available from: https://covid19.who.int/.

2. World Health Organization: Tracking SARS-CoV-2 variants. [cited 2022 July 16]. Available from: https://www.who.int/en/activities/tracking-SARS-CoV-2-variants.

3. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

4. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

5. Centers for Disease Control and Prevention: Underlying Medical Conditions Associated with Higher Risk for Severe COVID-19: Information for Healthcare Professionals. [cited 2022 May 2]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/underlyingconditions.html.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gastrointestinal symptoms in COVID-19 and disease severity: a Japanese registry-based retrospective cohort study;Journal of Gastroenterology;2024-01-25

2. Drug effectiveness for COVID-19 inpatients inferred from Japanese medical claim data using propensity score matching;F1000Research;2024-01-22

3. Prevalence of depressive symptoms and correlates among individuals who self-reported SARS-CoV-2 infection after optimizing the COVID-19 response in China;Frontiers in Public Health;2024-01-08

4. Post-discharge Healthcare Usage and Costs From March 2020 Through the Omicron Surge for Individuals Hospitalized With COVID-19;Cureus;2023-12-17

5. Does vaccination elicit risk compensation? Insights from the COVID-19 pandemic in France;Health Psychology and Behavioral Medicine;2023-11-30